PMPRB publishes annual Meds Pipeline Monitor report

Start
The Patented Medicine Prices Review Board (PMPRB) recently published its Meds Pipeline Monitor 2022 report, which highlights medicines in the pipeline that may impact future clinical practice and drug spending in Canada if approved for sale….
By: Smart & Biggar
Previous Story

The Intersection of Generative AI and Copyright Law

Next Story

Kennedy Krieger Institute Data Leaked Following MOVEit Data Breach at Johns Hopkins